- Home
- CSBR vs XBIT Comparison
CSBR vs XBIT Comparison
Compare CSBR & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- XBIT
- Stock Information
- Founded
- CSBR 1985
- XBIT 2005
- Country
- CSBR United States
- XBIT United States
- Employees
- CSBR N/A
- XBIT N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- XBIT Pharmaceuticals and Biotechnology
- Sector
- CSBR Health Care
- XBIT Health Care
- Exchange
- CSBR Nasdaq
- XBIT Nasdaq
- Market Cap
- CSBR 111.4M
- XBIT 93.0M
- IPO Year
- CSBR 1986
- XBIT 2015
- Fundamental
- Price
- CSBR $8.33
- XBIT $2.83
- Analyst Decision
- CSBR Strong Buy
- XBIT
- Analyst Count
- CSBR 1
- XBIT 0
- Target Price
- CSBR $12.00
- XBIT N/A
- AVG Volume (30 Days)
- CSBR 39.6K
- XBIT 185.9K
- Earning Date
- CSBR 09-10-2025
- XBIT 08-11-2025
- Dividend Yield
- CSBR N/A
- XBIT N/A
- EPS Growth
- CSBR N/A
- XBIT N/A
- EPS
- CSBR 0.46
- XBIT N/A
- Revenue
- CSBR $58,591,000.00
- XBIT N/A
- Revenue This Year
- CSBR $15.11
- XBIT N/A
- Revenue Next Year
- CSBR $7.80
- XBIT N/A
- P/E Ratio
- CSBR $17.71
- XBIT N/A
- Revenue Growth
- CSBR 19.03
- XBIT N/A
- 52 Week Low
- CSBR $3.60
- XBIT $2.50
- 52 Week High
- CSBR $11.99
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- CSBR 64.00
- XBIT 46.44
- Support Level
- CSBR $7.16
- XBIT $2.95
- Resistance Level
- CSBR $9.63
- XBIT $3.32
- Average True Range (ATR)
- CSBR 0.64
- XBIT 0.17
- MACD
- CSBR 0.11
- XBIT 0.01
- Stochastic Oscillator
- CSBR 69.06
- XBIT 40.24
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.